Vera Therapeutics Inc Cl A (VERA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -121,032 | -299,615 | -208,518 | -128,225 | -51,694 |
| Depreciation Amortization | -64 | -4,656 | -4,319 | -3,840 | -2,225 |
| Accounts payable and accrued liabilities | -7,966 | 13,910 | 10,285 | 5,492 | 1,597 |
| Other Working Capital | -13,728 | 22,992 | 12,630 | 3,944 | -9,438 |
| Other Operating Activity | 36,290 | 26,265 | 18,812 | 13,425 | 7,354 |
| Operating Cash Flow | $-106,500 | $-241,104 | $-171,110 | $-109,204 | $-54,406 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -23 | -630 | -528 | -395 | -187 |
| Purchase Of Investment | -210,561 | -310,446 | -285,947 | -187,251 | -89,992 |
| Sale Of Investment | 87,918 | 506,162 | 400,897 | 232,307 | 106,246 |
| Purchase Sale Intangibles | -150 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -15,150 | -800 | -800 | -800 | -750 |
| Investing Cash Flow | $-137,816 | $194,286 | $113,622 | $43,861 | $15,317 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,942 | 306,981 | 2,794 | 1,997 | 1,533 |
| Other Financing Activity | 0 | 1,916 | 19,821 | 19,821 | 0 |
| Financing Cash Flow | $3,942 | $308,897 | $22,615 | $21,818 | $1,533 |
| Beginning Cash Position | 354,725 | 92,646 | 92,646 | 92,646 | 92,646 |
| End Cash Position | 114,351 | 354,725 | 57,773 | 49,121 | 55,090 |
| Net Cash Flow | $-240,374 | $262,079 | $-34,873 | $-43,525 | $-37,556 |
| Free Cash Flow | |||||
| Operating Cash Flow | -106,500 | -241,104 | -171,110 | -109,204 | -54,406 |
| Capital Expenditure | -23 | -630 | -528 | -395 | -187 |
| Free Cash Flow | -106,523 | -241,734 | -171,638 | -109,599 | -54,593 |